Pediatric research in cancer
Executive Summary
FDA's Oncologic Drugs/Pediatric Subcommittee will meet Nov. 28 to discuss implementation of the pediatric rule including study design, ethical issues and extrapolating findings from adult to pediatric patients. The meeting will be held at the Holiday Inn in Gaithersburg, Md. beginning at 8 a.m